npj Genomic Medicine

Scope & Guideline

Empowering Global Collaboration in Genomics

Introduction

Explore the comprehensive scope of npj Genomic Medicine through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore npj Genomic Medicine in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN-
PublisherNATURE PORTFOLIO
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationNPJ GENOM MED / npj Genom. Med.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressHEIDELBERGER PLATZ 3, BERLIN 14197, GERMANY

Aims and Scopes

The journal 'npj Genomic Medicine' focuses on the intersection of genomics and medicine, emphasizing the application of genomic insights to clinical care and the understanding of genetic diseases. It aims to foster research that bridges the gap between genomic discoveries and their practical implications in medicine.
  1. Clinical Genomics and Personalized Medicine:
    The journal prioritizes research that utilizes genomic data to tailor medical treatments to individual patients, particularly in the context of rare genetic disorders and complex diseases.
  2. Genomic Technologies and Methodologies:
    A strong emphasis is placed on innovative genomic technologies, including sequencing techniques, bioinformatics, and data analysis methods that enhance the understanding of genetic variations and their implications.
  3. Population Genetics and Ethnic Diversity:
    Research exploring genetic diversity across different populations is a core area, highlighting the significance of ethnic backgrounds in genetic predisposition to diseases and responses to treatments.
  4. Integration of Genomics in Clinical Practice:
    The journal aims to report on the integration of genomic data into clinical workflows, including diagnostic applications, therapeutic strategies, and the ethical considerations surrounding genomic medicine.
  5. Disease Mechanisms and Genetic Contributions:
    Investigations into the genetic underpinnings of various diseases, including cancer, neurodevelopmental disorders, and cardiovascular conditions, are a significant focus, elucidating how genetic factors influence disease pathology.
Recent publications indicate several emerging themes that are gaining traction within 'npj Genomic Medicine', reflecting the journal's responsiveness to advancements in genomic technologies and clinical applications.
  1. Polygenic Risk Scores and Predictive Genomics:
    There is an increasing emphasis on polygenic risk scores as tools for predicting disease susceptibility and outcomes, showcasing their potential in personalized medicine and preventive healthcare.
  2. Integration of Multi-Omics Approaches:
    Emerging studies are increasingly adopting multi-omics strategies, integrating genomics with transcriptomics, proteomics, and metabolomics to provide a comprehensive understanding of disease mechanisms.
  3. Ethics and Inclusivity in Genomic Medicine:
    The journal is seeing a growing interest in the ethical implications of genomic research, particularly regarding inclusivity and representation in genetic studies, ensuring diverse populations are adequately represented.
  4. Real-World Applications of Genomic Data:
    Research is trending towards practical applications of genomic data in clinical settings, including the implementation of rapid genomic sequencing in urgent care scenarios and its impact on patient management.
  5. Advancements in Gene Editing Technologies:
    There is a surge in research focusing on gene editing technologies, such as CRISPR, and their potential therapeutic applications, indicating a shift towards innovative treatment strategies for genetic disorders.

Declining or Waning

While 'npj Genomic Medicine' continues to advance in various areas, certain themes have shown a decline in prominence over recent years. These waning scopes reflect changing research priorities and advancements in technology and understanding.
  1. Basic Genetic Research:
    Research focused solely on basic genetic mechanisms without direct clinical implications appears to be declining, as the journal emphasizes translational research that connects genetic findings to medical applications.
  2. Single-Disease Focus Studies:
    There is a noticeable decrease in studies that focus exclusively on single genetic disorders. Instead, the journal is increasingly featuring multi-disease approaches and integrative studies that consider the genetic basis of multiple conditions.
  3. Traditional Genetic Testing Approaches:
    With the advent of more sophisticated genomic sequencing technologies, traditional genetic testing methods are becoming less common in published research, as newer methods offer greater accuracy and broader insights.
  4. General Population Studies:
    The focus on broad population studies without specific clinical relevance is waning, with a shift towards studies that provide actionable insights for clinical practice and patient care.

Similar Journals

HUMAN GENETICS

Pioneering insights into human health and disease.
Publisher: SPRINGERISSN: 0340-6717Frequency: 12 issues/year

HUMAN GENETICS, published by SPRINGER, stands as a cornerstone journal in the field of genetics, offering a wealth of research insights since its inception in 1964. Hailing from Germany, this esteemed journal boasts an impressive Q1 ranking in both Genetics and Clinical Genetics, marking it among the top quartile of journals in these categories for 2023. With a notable Scopus rank of #7 in Clinical Genetics and a percentile ranking of 93, HUMAN GENETICS attracts significant attention from researchers and professionals dedicated to advancing our understanding of genetic influences on human health and disease. Although it does not currently offer Open Access options, the journal provides a critical platform for scholarly communication, aimed at disseminating groundbreaking findings in genetics and biotechnology. As the field evolves, HUMAN GENETICS continues to play an instrumental role in bridging the gap between laboratory research and clinical application, making it an essential resource for students and seasoned researchers alike.

Annual Review of Genomics and Human Genetics

Connecting Research and Discovery in Human Genetics
Publisher: ANNUAL REVIEWSISSN: 1527-8204Frequency: 1 issue/year

Annual Review of Genomics and Human Genetics, published by ANNUAL REVIEWS, represents a pivotal platform in the field of Genetics and Molecular Biology. With an impressive impact factor reflecting its high citation rate and scholarly influence, this journal is renowned for its authoritative reviews that synthesize current research across genomics and human genetics. Highlighting its Q1 category rankings in both Genetics and Clinical Genetics, as well as its ranking within the top tiers of Biochemistry and Genetics, the journal stands out as a leading resource for researchers, professionals, and students eager to stay abreast of groundbreaking developments in these rapidly evolving fields. While not currently an open access journal, its rigorous peer-review process ensures the highest standards of scientific integrity. Researchers can access comprehensive reviews that delve into both fundamental genetics concepts and cutting-edge discoveries, making it an essential resource for advancing understanding in human genetics and its applications.

GENOMICS

Illuminating the Path of Genetic Innovation
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0888-7543Frequency: 6 issues/year

GENOMICS is a prestigious journal published by Academic Press Inc Elsevier Science, dedicated to advancing the field of genetic research and molecular biology. With an impressive impact factor, this journal is recognized for its rigorous peer-review process and high-quality publications that cover a wide range of topics within the genomics discipline. Operating from the United States, GENOMICS has established itself as a vital resource for researchers, professionals, and students alike, standing at Q2 in the Genetics category according to the latest rankings. With a rich history dating back to 1987 and convergence extending to 2024, the journal highlights cutting-edge discoveries and methodologies, ensuring that its readership remains at the forefront of genetic advancements. Although currently not an open-access journal, articles published within its pages are often accessible through various academic platforms, enhancing worldwide reach and dissemination. For those engaged in the fields of biochemistry, genetics, and molecular biology, GENOMICS serves as an indispensable platform for impactful research and collaborative initiatives.

EUROPEAN JOURNAL OF HUMAN GENETICS

Exploring the Complexities of Heredity
Publisher: SPRINGERNATUREISSN: 1018-4813Frequency: 12 issues/year

The EUROPEAN JOURNAL OF HUMAN GENETICS, published by SpringerNature, stands as a preeminent platform in the field of genetics and clinical genetics. Established in 1993, this prestigious journal, with an ISSN of 1018-4813 and an E-ISSN of 1476-5438, has consistently maintained its position in the Q1 quartile for both Genetics and Clinical Genetics categories as of 2023, reflecting its significant contributions to the field. Its impact is further underscored by its impressive Scopus rankings, placing it in the 92nd percentile among clinical genetics journals. The journal aims to disseminate cutting-edge research, case studies, and reviews that advance our understanding of human genetics, promoting collaboration and innovation among researchers, professionals, and students alike. While it does not currently offer open access, the journal provides substantial value through its rigorous peer review process and commitment to quality. As it continues to shape the future of genetic research through 2024 and beyond, the EUROPEAN JOURNAL OF HUMAN GENETICS remains an essential resource for those dedicated to exploring the complexities of human heredity.

Frontiers in Genetics

Exploring Genetic Horizons Together
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Genetics is a premier academic journal dedicated to advancing the field of genetics through high-quality, peer-reviewed research. Published by FRONTIERS MEDIA SA in Switzerland since 2010, this Open Access journal provides a platform for researchers and practitioners to disseminate innovative findings across various subfields, including clinical genetics and molecular medicine. With a notable emphasis on interdisciplinary approaches, the journal holds a strong position in the academic landscape, achieving Q2 rankings in key categories such as Genetics and Molecular Medicine in 2023. Not only does Frontiers in Genetics contribute to the scholarly dialogue by publishing impactful studies, but it also promotes accessibility to vital research, ensuring that knowledge is available to a global audience. This journal is a vital resource for researchers, professionals, and students looking to stay at the forefront of genetic discoveries and their applications, reflective of its engagement with contemporary challenges in genetics and healthcare.

CYTOGENETIC AND GENOME RESEARCH

Empowering discoveries in clinical genetics through open access.
Publisher: KARGERISSN: 1424-8581Frequency: 12 issues/year

CYTOGENETIC AND GENOME RESEARCH is a pivotal journal dedicated to the exploration of cytogenetics, genomics, and their applications within clinical genetics and molecular biology. Published by KARGER in Switzerland, this journal aims to foster comprehensive discussions and disseminate impactful research from diverse fields related to genetics. It operates under an open access model, ensuring that researchers, professionals, and students can easily access and contribute to the latest findings. With coverage spanning from 1962 to 2024, CYTOGENETIC AND GENOME RESEARCH continues to serve as a vital resource, despite its current categorization in the Q4 quartile across Genetics and Molecular Biology. It provides an avenue for advancing the understanding of genomic mechanisms and their implications for human health. The journal encourages submissions that delve into cutting-edge methodologies, data interpretation, and theoretical frameworks, thereby playing a crucial role in the advancement of genetic research and its clinical applications.

Human Genome Variation

Bridging Research and Clinical Applications
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Human Genome Variation, published by SpringerNature, is an esteemed open access journal dedicated to the field of genetic research and exploration. Since its inception in 2014, the journal has been at the forefront of advancing our understanding of human genome diversity and its implications in health and disease. With an E-ISSN of 2054-345X, it features a diverse array of studies that encompass biochemistry, genetics, and molecular biology, making it an invaluable resource for researchers and professionals alike. The journal holds a Q3 ranking in both biochemistry and genetics, and a Q4 ranking in molecular biology, highlighting its growing influence within these disciplines. As the landscape of genomics continues to evolve, Human Genome Variation serves as a platform for the dissemination of high-quality research, fostering collaboration and innovation within the scientific community. Researchers and academics are invited to contribute to this pivotal journal, which not only provides open access to its content since 2014 but also aims to bridge the gap between basic research and clinical applications in genetics.

GENETICS AND MOLECULAR BIOLOGY

Advancing the frontiers of genetics and molecular biology.
Publisher: SOC BRASIL GENETICAISSN: 1415-4757Frequency: 4 issues/year

GENETICS AND MOLECULAR BIOLOGY, published by the SOC BRASIL GENETICA, is a prominent journal dedicated to the advancement of knowledge in the fields of genetics and molecular biology. Since its inception in 1998, this Open Access journal has served as a vital platform for researchers, professionals, and students to disseminate their findings and engage with the latest innovations and discoveries. With an impact factor that reflects its growing influence, GENETICS AND MOLECULAR BIOLOGY ranks in the Q3 category for both genetics and molecular biology as of 2023, indicating its position within the academic community. The journal is indexed in Scopus, highlighting its commitment to maintaining rigorous peer-review standards while providing wide-reaching access to quality research. Operating out of Ribeirão Preto, Brazil, it fosters a collaborative environment for academic discourse and research development not only in Brazil but also globally. The journal encourages submissions that explore a wide range of topics in genetics and molecular biology, making it an essential resource for anyone involved in these dynamic fields.

GENES & GENETIC SYSTEMS

Shaping the Future of Genetic Science and Medicine
Publisher: GENETICS SOC JAPANISSN: 1341-7568Frequency: 6 issues/year

GENES & GENETIC SYSTEMS, an esteemed journal published by the Genetics Society of Japan, serves as a vital platform for the dissemination of innovative research within the fields of genetics, molecular biology, and medicine. Established in 1996 and based in Mishima, Shizuoka, Japan, this journal has actively contributed to the academic community, fostering collaboration and knowledge sharing among researchers and professionals. The journal’s impact can be seen through its category quartiles, which reflect its position in Genetics, Molecular Biology, and Medicine, and while it currently ranks in Q4 in Genetics and Q3 in Medicine (miscellaneous), it is poised for growth as it continues to publish pivotal studies. With a commitment to open access, GENES & GENETIC SYSTEMS ensures that research findings are freely accessible to the global scientific community, promoting a more inclusive approach to knowledge distribution. This journal is essential for students, researchers, and professionals seeking to stay informed of advancements in genetic research and its implications for the broader field of medicine.

International Journal of Genomics

Transforming genomic research into global collaboration.
Publisher: HINDAWI LTDISSN: 2314-436XFrequency: 1 issue/year

International Journal of Genomics is a pivotal open-access publication under the esteemed HINDAWI LTD, dedicated to advancing the fields of genomics, biochemistry, genetics, and molecular biology. Established in 2013, this journal aims to disseminate innovative research findings and foster scholarly dialogue among researchers, professionals, and students alike. With a robust Impact Factor reflective of its commitment to quality, the journal has achieved a Q3 ranking in Biochemistry, Genetics, and Molecular Biology, as well as notable placements in Pharmaceutical Science, indicating its broad relevance and influence in these interconnected fields. The journal is indexed in esteemed databases, ensuring high visibility and accessibility for published works. As an open-access journal, it prioritizes the sharing of knowledge across borders, facilitating greater collaboration and advancement in genomic research globally. Join the academic community in exploring the vast potential of genomics through the International Journal of Genomics, based in Egypt, and reaching audiences worldwide from its London office.